154 related articles for article (PubMed ID: 24842110)
1. Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.
Przybyl J; Sciot R; Wozniak A; Schöffski P; Vanspauwen V; Samson I; Siedlecki JA; Rutkowski P; Debiec-Rychter M
Int J Biochem Cell Biol; 2014 Aug; 53():505-13. PubMed ID: 24842110
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
4. Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.
Orbach D; Mosseri V; Pissaloux D; Pierron G; Brennan B; Ferrari A; Chibon F; Bisogno G; De Salvo GL; Chakiba C; Corradini N; Minard-Colin V; Kelsey A; Ranchère-Vince D
Cancer Med; 2018 Apr; 7(4):1384-1393. PubMed ID: 29533008
[TBL] [Abstract][Full Text] [Related]
5. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.
Fletcher CD; Dal Cin P; de Wever I; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van den Berghe H; Vanni R; Willén H
Am J Pathol; 1999 Jun; 154(6):1841-7. PubMed ID: 10362810
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
7. Synovial sarcoma of the abdominal wall.
Fetsch JF; Meis JM
Cancer; 1993 Jul; 72(2):469-77. PubMed ID: 8391380
[TBL] [Abstract][Full Text] [Related]
8. Response to chemotherapy is not related to chromosome instability in synovial sarcoma.
Chakiba C; Lagarde P; Pissaloux D; Neuville A; Brulard C; Pérot G; Coindre JM; Terrier P; Ranchere-Vince D; Ferrari A; Collini P; Suurmeijer AJH; Blay JY; Terrisse SA; Piperno-Neumann S; Averous G; Bui B; Orbach D; Italiano A; Chibon F
Ann Oncol; 2014 Nov; 25(11):2267-2271. PubMed ID: 25070544
[TBL] [Abstract][Full Text] [Related]
9. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
10. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
11. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
Italiano A; Di Mauro I; Rapp J; Pierron G; Auger N; Alberti L; Chibon F; Escande F; Voegeli AC; Ghnassia JP; Keslair F; Laé M; Ranchère-Vince D; Terrier P; Baffert S; Coindre JM; Pedeutour F
Lancet Oncol; 2016 Apr; 17(4):532-538. PubMed ID: 26970672
[TBL] [Abstract][Full Text] [Related]
12. Synovial sarcoma of the vulva and vagina: a clinicopathologic and molecular genetic study of 4 cases.
Sumathi VP; Fisher C; Williams A; Meis JM; Ganesan R; Kindblom LG; McCluggage WG
Int J Gynecol Pathol; 2011 Jan; 30(1):84-91. PubMed ID: 21131827
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.
Fernebro J; Francis P; Edén P; Borg A; Panagopoulos I; Mertens F; Vallon-Christersson J; Akerman M; Rydholm A; Bauer HC; Mandahl N; Nilbert M
Int J Cancer; 2006 Mar; 118(5):1165-72. PubMed ID: 16152617
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and karyotype in recurrent and metastatic soft tissue sarcomas.
Van den Berg E; Molenaar WM; Hoekstra HJ; Kamps WA; de Jong B
Mod Pathol; 1992 Sep; 5(5):505-14. PubMed ID: 1344814
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.
El Beaino M; Araujo DM; Gopalakrishnan V; Lazar AJ; Lin PP
J Surg Oncol; 2016 Sep; 114(4):490-4. PubMed ID: 27220538
[TBL] [Abstract][Full Text] [Related]
16. Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease.
Vargas AC; Gray LA; White CL; Maclean FM; Grimison P; Ardakani NM; Bonar F; Algar EM; Cheah AL; Russell P; Mahar A; Gill AJ
Sci Rep; 2021 Jan; 11(1):667. PubMed ID: 33436720
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
[TBL] [Abstract][Full Text] [Related]
18. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions.
Al-Daraji W; Lasota J; Foss R; Miettinen M
Am J Surg Pathol; 2009 Oct; 33(10):1494-503. PubMed ID: 19623036
[TBL] [Abstract][Full Text] [Related]
19. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
20. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
